Non-alcoholic fatty pancreas disease (NAFPD) is generally defined as increased fat deposition in the pancreas [1], and is commonly associated with obesity and metabolic syndrome [2,3], as well as with metabolic dysfunction-associated steatotic liver disease (MASLD) [4–6]. While there is agreement on the impact of pancreatic steatosis on exocrine function [6–8], the effect of pancreatic steatosis on endocrine function is a widely discussed topic [8–11]. It is important to note that pancreatic fat…